Benjamin Adam Weinberg, MD| Hematology, Gastrointestinal Medical Oncology | MedStar Health
About me
Dr. Weinberg is an Associate Professor of Medicine and Attending Physician specializing in gastrointestinal medical oncology and sarcoma. Dr. Weinberg is focused on developing new therapies for colorectal and pancreatic cancers by translating research from animal models into early phase clinical trials in humans. He also studies young patients with colorectal cancer and their microbiome in order to understand the dramatic rise in incidence of left-sided colon and rectal cancers in this population.
Dr. Weinberg obtained his undergraduate degree in biomedical science at the University of Pennsylvania in 2007 and his MD at the Keck School of Medicine of the University of Southern California in 2011. He completed his post-graduate medical training at MedStar Georgetown University Hospital with a residency in internal medicine in 2014 and a fellowship in hematology and oncology in 2017 where he served as the Chief Fellow from 2016 to 2017.
Throughout his medical career, Dr. Weinberg has worked exhaustively to make sure that patients are heard and that they receive the highest quality of care. His training as a resident and fellow at Georgetown leads him in the pursuit of cura personalis (“care for the whole person”), and he brings this mindset every day into the clinic and all his work with patients.
Clinical areas of focus
- Bladder Carcinoma
- Colectomy
- Companionship
- Endoscopy With Biopsy
- Gastrectomy
- Gastric Surgery
- Hepatectomy
- Liver Biopsy
- Liver Metastases
- Pancreatectomy
- Rectal Cancer
- Small Intestine Cancer
Conditions and procedures
Conditions I treat
- Abnormal Tumor Markers
- Accessory Sinuses Cancer
- Acquired Hemolytic Anemia
- Anal Cancer
- Anemia
- Aplastic Anemia
- Aplastic Anemias And Bone Marrow Failure Syndromes
- Appendiceal Cancer
- Ascites
- B Cell Lymphoma
- Basal Cell Carcinoma Of Skin
- Benign Neoplasm Of Kidney
- Benign Neoplasm Of Skin
- Benign Neoplasm Of Urinary Organs
- Bile Duct Cancer
- Bladder Carcinoma
- Bone Marrow Failure Syndromes
- Bowel Obstruction
- Brain Tumor
- Breast Cancer
- Cancer Of The Appendix
- Cervical Cancer
- Chronic Eosinophilic Leukemia
- Colon Cancer
- Colonic Polyps
- Colorectal Malignancy
- Complications Of Infusion, Transfusion And Injection
- Crohn's Disease
- Crohn's Disease [Regional Enteritis]
- Disorders Of White Blood Cells
- Esophageal Adenocarcinoma
- Esophageal Cancer
- Familial Adenomatous Polyposis (FAP)
- Family History Of Malignant Neoplasm
- Gallbladder Cancer
- Gastric Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Hemorrhagic Conditions
- Hepatoblastoma
- Intrahepatic Bile Ducts Cancer
- Kaposi's Sarcoma
- Kidney Cancer
- Leukopenia
- Liver Cancer
- Liver Metastases
- Lung Cancer
- Lynch Syndrome
- Malaise And Fatigue
- Malignant Immunoproliferative Diseases And B
- Malignant Neoplasm
- Malignant Neoplasm Of Bladder
- Malignant Neoplasm Of Cervix Uteri
- Malignant Neoplasm Of Connective And Soft Tissue
- Malignant Neoplasm Of Endocrine Glands
- Malignant Neoplasm Of Eye And Adnexa
- Malignant Neoplasm Of Heart, Mediastinum And Pleura
- Malignant Neoplasm Of Lymph Nodes
- Malignant Neoplasm Of Ovary
- Malignant Neoplasm Of Retroperitoneum
- Malignant Neoplasm Of Testicle
- Malignant Neoplasm Of Ureter
- Malignant Neuroendocrine Tumors
- Multiple Myeloma
- Myelodysplastic Syndromes (MDS)
- Myopathies
- Neoplasm Analysis
- Neoplasm Of Uncertain Behavior
- Neoplasms Of Lymphoid, Hematopoietic And Related Tissue
- Neutropenia
- Noninfective Gastroenteritis
- Ovarian Cancer
- Ovarian Germ Cell Tumor
- Pancreas Cancer
- Pancreatic Adenocarcinoma
- Pancytopenia
- Papillary Carcinoma Of Breast
- Pericardium Diseases
- Personal History Of Medical Treatment
- Plasma Cell Neoplasms
- Pulmonary Embolism
- Purpura
- Rectal Cancer
- Secondary Malignant Neoplasm Of Brain
- Small Intestine Cancer
- Stomach Cancer
- Subclinical Hypothyroidism
- Testicular Cancer
- Thalassemia
- Thrombocytopenia
- Tonsil Cancer
- Ulcerative Colitis
- Uterine Cancer
- Venous Embolism
- Vitamin Deficiency Anemia
Procedures I perform
- Abdominal Wall Biopsy
- Abdominal Wall Tumor Resection
- Antiangiogenic Therapy
- Antineoplastic Injection
- Blood Banking
- Blood Transfusion
- Bone Cancer Staging
- Bone Marrow Aspiration
- Cancer Rehabilitation
- Cancer Risk Assessment
- Cancer Survivorship Care
- Cancer Treatment Monitoring
- Cardiac Cell Therapy
- Central Nervous System Biopsy
- Cervical Lymph Node Dissection
- Chemoradiation
- Chemotherapy Administration
- Cholecystectomy
- Clinical Trials
- Cold Laser Therapy
- Colectomy
- Companionship
- Computerized Tomography (CT) Scan
- Dopamine Therapy
- Endoscopic Clip Placement
- Endoscopic Mucosal Resection
- Endoscopy With Biopsy
- Esophageal Cancer Diagnosis
- Etoposide Therapy
- Fine Needle Aspiration Biopsy
- Gastrectomy
- Gastric Surgery
- Genetic Counseling
- Gynecological Cancer Screening
- Hematology Consultation
- Hepatectomy
- Hepatic Artery Infusion
- Imiquimod Treatment
- Immune Cell Therapy Administration
- Immunoglobulin Administration
- Immunotherapy
- Inpatient Palliative Care
- Internal Jugular Central Line Placement
- Internal Radiation Therapy
- Intra-Arterial Infusion Of Chemotherapy
- Introduction Of Antineoplastic
- Laparoscopic Revision Of Gastric Restrictive Procedure
- Laparoscopy
- Laser Therapy
- Live-In Care
- Liver Biopsy
- Liver Transplant
- Liver Tumor Ablation
- Low Anterior Resection
- Minimally Invasive Surgery
- Nanoknife
- Oncology Consultation
- Pain Medication Management
- Palliative Care
- Pancreatectomy
- Parotid Biopsy
- Percutaneous Tumor Chemoembolization
- Perianal Surgery
- Peripheral Blood Stem Cell Transplantation
- Pharmacological Imaging
- Platelet Transfusion
- Proton Beam Radiosurgery
- Radiation Therapy
- Radiopharmaceutical Therapy
- Red Blood Cell Transfusion
- Removal Of Central Venous Access Device
- Sentinel Lymph Node Mapping
- Stem Cell Harvesting
- Surgical Oncology Surgery
- Therasphere Therapy
- Thoracoscopic Biopsy
- Thrombocytapheresis
- Tobramycin Administration
- Total Parenteral Nutrition
- Transarterial Embolization
- Transrectal Ultrasound
- Tumor Embolization
- Tumor Immunohistochemistry
- Tumor Marker Testing
- Tumor Resection
- Ultrasound-Guided Biopsy
- Venous Access Device Irrigation
- Venous Blood Collection
- Von Willebrand Factor Replacement
- Wellness Services
- White Blood Cell Transfusion
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- CIGNA HMO & Network (HMO)
- Aetna Better Health of MD
- Anthem BCBS of VA HealthKeepers Plus
- CareFirst Blue Choice Opt Out Open Access
- Anthem BCBS Medi Blue SNP
- Johns Hopkins Advantage MD HMO
- CareFirst (NCA) Indemnity
- CareFirst FEP Blue Focus
- United Healthcare Select Plus (POS)
- Aetna Advantage 6350PD
- Optima Family Care MCO - VA Medicaid MCO
- HUMANA/Choice Care Medicare Plans (Choice, Gold Choice)
- United Healthcare Navigate Cardiac Global
- Kaiser Permanente Select Cardiac Global
- IH-Open Network Only Plus
- AmeriHealth Caritas DC Healthy Families
- Kaiser Permanente Signature - Added Choice
- Healthy Blue (HMO, POS)
- HumanaChoice Honor's plan PPO
- UHC Passport
- Optimum Choice Preferred (POS)
- UnitedHealthcare Medicare Adv. Special Needs Plans
- IH-Network Only Plus
- First Health PPO
- Priority Partners - Maryland Health Choice
- Humana Gold Plus HMO
- Aetna Worker's Compensation Network
- Coventry of Delaware HMO/PPO
- OCI Direct (HMO)
- United Healthcare Choice Plus Cardiac Global
- Alterwood Advanatge HMO & DSNP Plans
- AMERIVANTAGE/Amerigroup Community Care
- Medicare Direct
- UHC Group Medicare Advantage Plans (HMO, POS, PPO)
- CareFirst Community Health Plan of MD
- Kaiser Permaenete Signature - Added Choice Cardiac Global
- United Medicare Private Fee-for-Service (PFFS) plans
- Aetna Traditional Choice (PPO)
- UnitedHealthcare and AARP Medicare Complete Plans
- CareFirst NASCO
- Cigna Alliance Medicare (HMO)
- Choice POS
- Optimum Choice
- Mamsi Life & Health (Indem./PPO) Cardiac Global
- HumanaChoice PPO
- Amerigroup DC Healthy Families
- United Healthcare Choice Plus
- AmeriHealth Caritas DC Healthcare Alliance
- CareFirst Blue Card Program
- IH-Indemnity
- CareFirst BlueChoice HMO
- Police and Fire Clinic
- Jai Medical Systems - Maryland Health Choice
- Anthem BCBS Medi Blue Plus
- Options PPO Cardiac Global
- Aetna Classic 3500
- Medicare FFS
- Amerigroup DC Alliance
- MedStar Family Choice - Maryland Health Choice
- IH-Open EPO Plus
- IH-PPO
- TriWest Healthcare Alliance
- Choice Care Network/HUMANA (PPO)
- Coventry Health Care National Network PPO
- CIGNA POS/Network POS
- UnitedHealthcare Individual Exchange Plans
- Choice POS II Open Access
- IH-Open POS Plus
- Choice Fund PPO
- MD IPA (HMO) & MD IPA Preferred Cardiac Global
- Aetna Elect Choice/ Open Access (POS)
- United Student Resources
- Optimum Choice & Optimum Choice Preferred (POS) Cardiac Global
- Cigna TotalCare (HMO D-SNP)
- Kaiser Permanente Flexible Choice 3-tier POS
- Anthem BCBS of VA Key Care POS/PPO/Indemnity
- CareFirst Federal Employee Program (Std. & Basic PPO)
- Kaiser Permanente Signature
- United Healthcare Community Plan - VA Medicaid MCO
- Core Essential (HMO)
- IH-POS
- CareFirst MedStar PPO
- Aetna Signature Administrator PPO/TPA
- Geisinger Medicare Advantage
- United Healthcare Options (PPO)
- Kaiser Permanente Flexible Choice POS Cardiac Global
- CIGNA EPO
- CareFirst Administrators
- Select HMO/HealthFund/Health Network
- CareFirst Maryland Point of Service Plan
- Aetna Student Health Insurance
- NYC Medicare Advantage Plus
- Aetna HMO
- Humana Medicare Advantage - PPO
- TRICARE for Life East
- Anthem Federal Employee Program Basic
- Cigna True Choice Plus Medicare (PPO)
- CareFirst Maryland Indemnity or PPO
- CIGNA SureFit (HMO)
- Aetna Advantage 6350
- Aetna Better Health of VA
- CareFirst MedStar Select PPO
- CIGNA HMO Open Access
- M.D. IPA Preferred (POS)
- IH-HMO
- Choice POS II
- Aetna VA Exchange
- CareFirst BlueCross BlueShield Advantage Core/Enhanced
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- Tricare Reserve Select
- Aetna Open Choice (PPO)
- Health Services for Children with Special Needs
- Veterans Affairs Community Care Network
- DC/MD SHOP QHP Small Business Plans
- Aetna Basic
- CareFirst Blue Choice Opt Out Plus Open Access (POS)
- United Healthcare Select HMO - EPO/NPP
- BlueChoice Open Access
- Cigna Preferred Medicare (HMO)
- Aetna Classic 5000
- Aetna Medicare Advantage HMO & PPO Plans
- Mamsi Life & Health (Indem./PPO)
- Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
- CIGNA Indemnity
- Aetna Managed Choice (POS)
- Kaiser Permanente Medicare Advantage Signature and Select
- Navigate
- United Healthcare Choice
- Blue Choice Advantage
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- HealthyBlue PPO
- Kaiser Permanente HMO Plus and DHMO Plus Member
- CareFirst Group Medicare Advantage
- WellPoint Maryland - Maryland Health Choice
- Coventry Health Care of Virginia
- Aetna Classic 5000PD
- Uniformed Services Family Health Plan
- Mamsi Life & Health (Indem./PPO)
- Network OA
- Sentara Health
- MedStar Family Choice DC Healthy Families
- IH-Open HMO Option
- Aetna Quality Point of Service (POS)
- CareFirst EPO
- M.D. IPA (HMO)
- Beech Street PPO
- Cigna Achieve Medicare (HMO C-SNP)
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- IH-Open HMO
- Great-West Healthcare POS/CIGNA
- Employee Health Plan
- BCBS Out-of-State Medicare Plans (Blue Advantage)
- Magellan Complete Care of VA - VA Medicaid MCO
- Private Health Care Systems (PPO)
- CareFirst Dual Prime HMO-SNP
- Aetna Premier 200PD
- Anthem BCBS Medi Blue Dual Adv
- POS OA
- CIGNA PPO
- United Healthcare Choice Cardiac Global
- Advantra Platinum (PPO)
- Kaiser Permanente Select - Added Choice
- BCBS of Michigan (BCN Advantage,Security Blue, Freedom, Medicare PLUS Blue Group PPO)
- MultiPlan, Inc
- United Healthcare Select HMO-EPO/NPP Cardiac Global
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- Aetna Managed Choice Open Access (POS)
- HighMark
- MedStar Family Choice - Maryland Health Choice
- Erickson Advantage Plans
- Humana Medicare Advantage - HMO Open Access
- TRICARE East Select
- Anthem BCBS of VA HealthKeepers (HMO)
- Maryland Physicians Care MCO
- Private Fee-for-Service Plans (PFFS)
- Anthem Federal Employee Program Standard
- Lasso Healthcare - Medicare Medical Savings Account
- CIGNA PPO Plus
- Kaiser Permanente Medicare Plus
- United HealthCare Community Plan - Maryland Health Choice Program
- IH-Open POS II
- CareFirst Blue Preferred PPO
- Kaiser Maryland Medicaid MCO
- CIGNA Connect EPO
- OA Plus
- MedStar Family Choice DC Healthcare Alliance
- UnitedHealthcare Individual Exchange Plans
- Medicare Advantage - Advantra Value (PPO)
- Anthem BCBS of VA HealthKeepers (POS & POS OA)
- First Health PPO
- Cigna True Choice Medicare (PPO)
- IH-EPO Plus
- Aetna Medicare Advantage PFFS Plan
- Kaiser Permanente Select
- UnitedHealthcare Medicare Advantage DSNP District of Columbia
- IH-POS Plus
- Johns Hopkins Advantage MD PPO
- TRICARE East Prime
- Aetna Advantage 5750
- Johns Hopkins Advantage MD PLUS PPO
- MedStar Family Choice DC Healthcare Alliance
Videos
Education
Board Certification: American Board of Internal Medicine, Internal Medicine
Fellowship: Georgetown University Hospital (2017)
Residency: Georgetown University Hospital (2014)
Medical School: University of Southern California (2011)
Awards
- HemeOnc Today's Next Gen Innovator, June 2019
- First Place, Fellow Clinical Research Award, Georgetown Department of Medicine Research Day
- 2017 Conquer Cancer Foundation Gastrointestinal Cancers Symposium Merit Award
- 2016 Conquer Cancer Foundation of ASCO Young Investigator Award
- AACR/ASCO Workshop on Methods in Clinical Cancer Research Invited Participant, Vail, CO
- Donald E. and Delia B. Baxter Foundation Award
- Medical Student Summer Research Fellowship, Keck School of Medicine
- Dean’s Recognition, Keck School of Medicine of the University of Southern California
- NIH Summer Intramural Research Training Award Fellowships
Hospital affiliations
News and publications
Original Papers
- Weinberg BA, Winslow RW, Bayasi M, Krainock MR, Olshan PM, Billings PR, Aleshin A, George GV. Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer. Case Reports in Oncology, 2021; in press.
- Arai H, Elliott A, Millstein J, Xiu J, Ou F, Innocenti F, Wang J, Battaglin F, Jayachandran P, Kawanish N, Soni S, Zhang W, Sohal D, Goldberg RM, Hall MJ, Scott AJ, Khushman M, Hwang JJ, Lou E, Weinberg BA, Lockhart AC, Shields AF, Abraham JP, Magee D, Stafford P, Zhang J, Venook AP, Korn WM, Lenz HJ. Molecular characteristics and clinical outcomes of patients with neurofibromin 1-altered metastatic colorectal cancer. Oncogene, 2021; epub ahead of print. doi: 10.1038/s41388-021-02074-z. PubMed PMID: 34728807.
- Malchiodi ZX, Cao H, Gay MD, Safronenka A, Bansal S, Tucker RD, Weinberg BA, Cheema A, Shivapurkar N, Smith JP. Cholecystokinin receptor antagonist improves efficacy of chemotherapy in murine pancreatic cancer by altering tumor microenvironment. Cancers (Basel), 2021 Sep;13(10):4949. doi: 10.3390/cancers13194949. PubMed PMID: 34638432.
- Armstrong SA, Malley R, Wang H, Lenz HJ, Arguello D, El-Deiry WS, Xiu J, Gatalica Z, Hwang JJ, Philip PA, Shields AF, Marshall JL, Salem ME‡, Weinberg BA‡. Molecular characteristics of anal squamous cell carcinoma. Journal of Gastrointestinal Oncology, 2021; epub ahead of print (‡Co-senior authors). doi: 10.21037/jgo-20-610.
- Loree JM, Wang Y, Syed MA, Sorokin AV, Coker O, Xiu J, Weinberg BA, VanderWalde AM, Tesfaye A, Raymond VM, Miron B, Tarcic G, Zelichov O, Broaddus RR, Ng PKS, Jeong KJ, Tsang YH, Mills GB, Overman MJ, Grothey A, Marshall JL, Kopetz S. Clinical and functional characterization of atypical KRAS/NRAS mutations in metastatic colorectal cancer. Clinical Cancer Research, 2021; epub ahead of print. doi: 10.1158/1078-0432.CCR-21-0180. PubMed PMID: 34117033.
- Lou E, Xiu J, Baca Y, Nelson AC, Weinberg BA, Beg MS, Salem ME, Lenz HJ, Philip P, El-Deiry W, Korn WM. Expression of immuno-oncologic biomarkers is enriched in colorectal cancers and other solid tumors harboring the A59T variant of KRAS. Cells, May 21;10(6):1275. doi: 10.3390/cells10061275. PubMed PMID: 3406399; PubMed Central PMCID: PMC8224072.
- Wang J, Xiu J, Baca Y, Arai H, Battaglin F, Kawanishi N, Soni S, Zhang W, Millstein J, Shields AF, Grothey A, Weinberg BA, Marshall JL, Lou E, Khushman M, Sohal DPS, Hall MJ, Oberley M, Spetzler D, Shen L, Korn WM, Lenz HJ. Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy. Annals of Oncology, 2021; epub ahead of print.
- Arai H, Elliott A, Xiu J, Wang J, Battaglin F, Kawanishi N, Soni S, Zhang W, Millstein J, Sohal D, Goldberg RM, Hall MJ, Scott AJ, Khushman M, Hwang JJ, Lou E, Weinberg BA, Marshall JL, Lockhart AC, Stafford P, Zhang J, Moretto R, Cremolini C, Korn WM. The landscape of the DNA damage response pathways in colorectal cancer. Clinical Cancer Research, 2021; epub ahead of print.
- Borden BA, Baca Y, Xiu J, Tavora F, Winer I, Weinberg BA, VanderWalde AM, Darabi S, Korn WM, Mazar AP, Giles FJ, Crawford L, Saftran H, El-Deiry WS. The landscape of glycogen synthase kinase-3 beta (GSK-3b) genomic alterations in cancer. Molecular Cancer Therapeutics, 2020; epub ahead of print. doi: 10.1158/1535-7163.MCT_20-0497. PubMed PMID: 33087512.
- Cadranel J, Liu SV, Duruisseaux M, Branden E, Goto Y, Weinberg BA, Hening C, Schlenk RF, Cheema P, Jones MR, Drilon A, Trombetta D, Muscarella LA, Tolba K, Gounant V, Cseh A, Solca F, Laskin JJ, Renouf DJ. Therapeutic potential of afatinib in NRG1 fusion-driven solid tumors: a case series. The Oncologist, 2020 Aug; epub ahead of print. doi: 10.1634/theoncologist.2020-0379. PMID: 32852072.
- Weinberg BA, Wang H, Witkiewicz AK, Marshall JL, He AR, Vail P, Knudsen ES, Pishvaian MJ. A phase I study of ribociclib plus everolimus in patients with metastatic pancreatic adenocarcinoma refractory to chemotherapy. Journal of Pancreatic Cancer, 2020;6(1):1-10. doi: 10.1089/pancan.2020.0005. PubMed Central PMCID: PMC7337242.
- Pishvaian MJ, Wang H, He AR, Hwang JJ, Smaglo BG, Kim SS, Weinberg BA, Weiner LM, Marshall JL, Brody JR. A phase I/II study of veliparib (ABT-888) in combination with 5-fluorouracil and oxaliplatin in patients with metastatic pancreatic cancer. Clinical Cancer Research, 2020 Oct;26(19):5092-5101. doi: 10.1158/1078-0432.CCR-20-1301.
- Mody K, Starr J, Saul M, Poorman K, Weinberg BA, Salem ME, VanderWalde A, Shields AF. Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers. Journal of Gastrointestinal Oncology, 2019 Dec;10(6):1099-1109. doi: 10.21037/jgo.2019.08.08. PubMed PMID: 31949927; PubMed Central PMCID: PMC6955012.
- Weinberg BA, Xiu J, Lindberg MR, Shields AF, Hwang JJ, Poorman K, Salem ME, Pishvaian MJ, Holcombe RF, Marshall JL, Morse MA. Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets. Journal of Gastrointestinal Oncology, 2019 Aug;10(4):652-662. doi: 10.21037/jgo.2018.08.18. PubMed PMID: 31392046; PubMed Central PMCID: PMC6657312.
- Salem ME, Yin J, Weinberg BA, Renfro LA, Pederson LD, Maughan TS, Adams RA, Van Cutsem E, Falcone A, Tebbutt NC, Seymour MT, Díaz-Rubio E, Aranda E, Bokemeyer C, Heinemann V, Wasan H, de Gramont A, Grothey A, Shi Q, Sargent DJ, Marshall JL. Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. European Journal of Cancer, 2018 Nov;103:205-213. doi: 10.1016/j.ejca.2018.08.020. Epub 2018 Sep 27. PubMed PMID: 30268921.
- Puccini A, Lenz HJ, Marshall JL, Arguello D, Raghavan D, Korn WM, Weinberg BA, Poorman K, Heeke AL, Philip PA, Shields AF, Goldberg RM, Salem ME. Impact of patient age on molecular alterations of the left-sided colorectal tumors. The Oncologist, 2019 Mar;24(3):319-326. doi: 10.1634/theoncologist.2018-0117. Epub 2018 July 17. PubMed PMID: 30018131; PubMed Central PMCID: PMC6519749.
- Weinberg BA, Xiu J, Hwang JJ, Shields AF, Salem ME, Marshall JL. Immuno-oncology biomarkers for gastric and gastroesophageal junction adenocarcinoma: why PD-L1 testing may not be enough. The Oncologist, 2018 Oct;23(10):1171-1177. doi: 10.1634/theoncologist.2018-0034. Epub 2018 Apr 27. PubMed PMID: 29703766; PubMed Central PMCID: PMC6263127.
- Salem ME, Puccini A, Grothey A, Raghavan D, Goldberg RM, Xiu J, Korn WM, Weinberg BA, Hwang JJ, Shields AF, Marshall JL, Philip PA, Lenz HJ. Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers. Molecular Cancer Research, 2018 May;16(5):805-812. doi: 10.1158/1541-7786.MCR-17-0735. Epub 2018 Mar 9. PubMed PMID: 29523759; PubMed Central PMCID: PMC6833953.
- ‡Salem ME, ‡Weinberg BA, Xiu J, El-Deiry WS, Hwang JJ, Gatalica Z, Philip PA, Shields AF, Lenz HJ, Marshall JL. Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. Oncotarget, 2017 Oct 17;8(49):86356-86368. doi: 10.18632/oncotarget.21169. Epub 2017 Sep 21. PubMed PMID: 29156800; PubMed Central PMCID: PMC5689690. (‡Co-first authors).
- Weinberg BA, Gowen K, Lee TK, Ou SH, Bristow R, Krill L, Almira-Suarez MI, Ali SM, Miller VA, Liu SV, Klempner SJ. Comprehensive genomic profiling aids in distinguishing metastatic recurrence from second primary cancers. The Oncologist, 2017 Feb;22(2):152-157. doi: 10.1634/theoncologist.2015-0511. Epub 2017 Feb 13. PubMed PMID: 28193735; PubMed Central PMCID: PMC5330711.
- Weinberg BA, Wang H, Yang X, Wu CS, Pishvaian MJ, He AR, Marshall JL, Hwang JJ. Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy, a retrospective cohort study. Gastrointestinal Cancer Research, 2014 May;7(3-4):91-97. PubMed PMID: 25276262; PubMed Central PMCID: PMC4171974.
- El-Chemaly S, Malide D, Zudaire E, Ikeda Y, Weinberg BA, Pacheco-Rodriguez G, Rosas IO, Aparicio M, Ren P, MacDonald SD, Wu HP, Nathan SD, Cuttitta F, McCoy JP, Gochuico BR, Moss J. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 2009 Mar;106(10):3958-3963. doi: 10.1073/pnac.0813368106. Epub 2009 Feb 23. PubMed PMID: 19237567; PubMed Central PMCID: PMC2646625.
- Xiao J, Pohlmann PR, Issacs C, Weinberg BA, He AR, Schlegel R, Agarwal S. Circulating tumor cells: technologies and their clinical potential in cancer metastasis. Biomedicines, 2021 Aug;9(9):1111. doi: 10.3390/biomedicines9091111. PubMed PMID: 34572297.
- REACCT Collaborative, Zaborowski AM, A....Weinberg BA..., Wells C, Wolthuis A, Xynos E, You N, Zakharenko A, Zeballos J, Winter DC. Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surgery, 2021; epub ahead of print. doi: 10.1001/jamasurg.2021.2380. PubMed PMID: 34190968.
- Armstrong SA, Malley R, Weinberg BA. Molecular profiling in metastatic colorectal cancer. Oncology (Williston Park), 2020 Sep;34(9):352-355. doi: 10.46883/ONC.2020.3409.0352. PubMed PMID: 32965665.
- Armstrong SA, Malley R, Weinberg BA. Glimmers of hope: new strategies for overcoming resistance in patients with BRAF V600E-mutated metastatic colorectal cancer. Oncology & Hematology Review (US), 2020 Jul;16(1):31-35.
- Mukherji R, Weinberg BA. The gut microbiome and potential implications for early-onset colorectal cancer. Colorectal Cancer, 2020 Epub 2020 Oct;9(1). doi: 10.2217/crc-2020-0007.
- Marshall JL, Yarden RI, Weinberg BA. Colorectal cancer in the age of coronavirus – strategies to reduce risk and maintain benefit. Colorectal Cancer, Epub 2020 Apr;9(1). doi: 10.2217/crc-2020-0010. PubMed Central PMCID: PMC7170009.
- Weinberg BA, Hameed R, Marshall JL. Biomarkers for immune therapy in gastrointestinal cancers. Clinical Advances in Hematology & Oncology, 2019 Feb;17(2):109-119. PubMed PMID: 30845114.
- Weinberg BA, Marshall JL. Colon cancer in young adults: trends and their implications. Current Oncology Reports, 2019 Jan 18;21(1):3. doi: 10.1007/s11912-019-0756-8. PubMed PMID: 30659375.
- Weinberg BA. Anti-EGFR therapy in right-sided metastatic colorectal cancer: right or wrong? Journal of the National Comprehensive Cancer Network, 2018 Dec;16(12):1547-1548. doi: 10.6004/jnccn.2018.7107. PubMed PMID: 30545999.
- Puthiamadathil JM, Weinberg BA. Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil. Cancer Management and Research, 2017 Oct;9:461-469. doi: 10.2147/CMAR.S113320. PubMed PMID: 29056855; PubMed Central PMCID: PMC5635852.
- Serzan MT, Weinberg BA, Salem ME. Second-line therapy in advanced colorectal cancer: EGFR vs. continuation of VEGF inhibition. Current Colorectal Cancer Reports, 2017 Sep 18;13(6):411-418. doi: 10.1007/s11888-017-0388-z.
- Weinberg BA, Hartley M, Salem ME. Precision medicine in metastatic colorectal cancer: relevant carcinogenic pathways and targets. Part 1: biologic therapy targeting epidermal growth factor receptor and vascular endothelial growth factor. Oncology (Williston Park), 2017 Jul;31(7):539-548. PubMed PMID: 28712098.
- Weinberg BA, Hartley M, Salem ME. Precision medicine in metastatic colorectal cancer: relevant carcinogenic pathways and targets. Part 2: approaches beyond first-line therapy, and novel biologic agents under investigation. Oncology (Williston Park), 2017 Jul;31(7):573-580. PubMed PMID: 28712102.
- Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncology (Williston Park), 2017 May;31(5):381-389. PubMed PMID: 28516436.
- Weinberg BA, Philip PA, Salem ME. Evolving standards of care for resected pancreatic cancer. Clinical Advances in Hematology & Oncology, 2017 Feb;15(2):141-150. PubMed PMID: 28398285.
- Weinberg BA, Marshall JL, Salem ME. Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer. Clinical Advances in Hematology & Oncology, 2016 Aug;14(8):630-638. PubMed PMID: 27487107.
- Weinberg BA, Marshall JL, Hartley M, Salem ME. A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer. Clinical Advances in Hematology & Oncology, 2016 Feb;14(2):116-128. PubMed PMID: 27057810.
- Weinberg BA, Yabar CS, Brody JR, Pishvaian MJ. Current standards and novel treatment options for metastatic pancreatic adenocarcinoma. Oncology (Williston Park), 2015 Nov;29(11):809-820, 886. PubMed PMID: 26573060.